Arkema surfs the chemicals wave well, being carried along by the strong recovery. Supply availability is one side of the coin. On the other, stands cash collection and the company was good at this. Business-wise, the paved path seems to be a well-chosen one.
We appreciate the guidance increase, but do not understand that it is based on an unchanged scope after the closing the PMMA divestment.
Consensus was beaten by +5.7% (top line) and +21% (adjusted EBITDA).
29 Jul 2021
NWC inflows despite strong growth
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
NWC inflows despite strong growth
Arkema surfs the chemicals wave well, being carried along by the strong recovery. Supply availability is one side of the coin. On the other, stands cash collection and the company was good at this. Business-wise, the paved path seems to be a well-chosen one.
We appreciate the guidance increase, but do not understand that it is based on an unchanged scope after the closing the PMMA divestment.
Consensus was beaten by +5.7% (top line) and +21% (adjusted EBITDA).